The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality - Trial NCT06420479
Access comprehensive clinical trial information for NCT06420479 through Pure Global AI's free database. This phase not specified trial is sponsored by Karolinska Institutet and is currently Recruiting. The study focuses on Bariatric Surgery Candidate,Cardiovascular Diseases,Morality. Target enrollment is 100000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Karolinska Institutet
Timeline & Enrollment
N/A
Jan 01, 2024
Dec 31, 2027
Primary Outcome
Cardiovascular disease
Summary
The association between weight, and cardiovascular disease and mortality is well established,
 however, the causal effect of weight-loss in midlife on these outcomes is less clear.
 Bariatric surgery results in substantial weight-loss and is an ideal candidate to study the
 causal effects of weight-loss. We propose a project that will use causal inference and
 machine learning methods to answer two important questions:
 
 1. Is bariatric surgery effective for reducing cardiovascular disease and mortality, and if
 so, for who?
 
 2. Which type of bariatric surgery (gastric bypass or sleeve gastrectomy) is most
 effective, and for who? We will use data from various Swedish registers to identify
 individuals with obesity who are eligible for bariatric surgery. We will then compare
 cardiovascular and mortality outcomes among those undergoing different types of
 bariatric surgery with those receiving non-surgical obesity management using causal
 inference methods. We will use causal forests and expert knowledge to estimate indiviual
 treatment effects, and identify the groups of patients who benefit the most from these
 surgeries.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06420479
Non-Device Trial

